Oragenics Initiates a Pivotal IND-Enabling Toxicology Study on Its Intranasal COVID-19 Vaccine Candidate, NT-CoV2-1
Oragenics, Inc., announced the initiation of a Good Laboratory Practice (GLP) toxicology study to evaluate the safety profile and immunogenicity of its NT-CoV2-1 vaccine
Exactech Announces New Patent, Strengthening Company’s Position in Joint Replacement Soft Tissue Management
UF startup Exactech, announces new patent or the Newton™ Knee, a dynamic platform of cutting-edge technology used with forward-thinking implants that are designed to provide optimal balance in a reproducible way.
Dialectic Therapeutics Announces DT2216 Has Received Orphan Drug Designation From the FDA for the Treatment of T-Cell Lymphoma
UF startup Dialectic Therapeutics, Inc. (Dialectic®), announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to DT2216 for the treatment of T-cell lymphoma.
Lacerta Therapeutics Expands Executive Leadership Team
UF startup Lacerta Therapeutics, a preclinical-stage gene therapy company, announces an expansion in the executive leadership team: illustrating Lacerta’s commitment to developing a constellation of gene-based therapies.
RTI Surgical: Plant Director’s Passion and Engagement Inspires Team
A passion to find a position with a company that directly impacts people’s lives led Catisha Turner to join UF startup RTI Surgical, after serving in the United States Navy for six years.
Cannabix Technologies Presents FAIMS Marijuana Breathalyzer Technology at the Texas Impaired Driving Forum
UF startup Cannabix Technologies Inc., presented key innovations for first-of-its-kind marijuana breath detection technology. This comes at a time when legislators are grappling with the ever-increasing problem of drugged driving.
Capri EGM Build-to-Suit Program Acquires Life Science Real Estate Asset for Company Manufacturing Antibodies for Department of Defense and mRNA for COVID-19 Vaccine
UF startup Ology Bioservices, a wholly owned subsidiary of Resilience, and the operator of the Lab & Research facility, has recently been awarded contract valued as much as $250 million by the Department of Defense for manufacturing development of a monoclonal antibody as a medical countermeasure (MCM) to botulinum neurotoxins (BoNT).
Mental Health Benefits: A Must-Have Resource for Employees
“Mental health benefits are just as important as physical health benefits,” says Dr. Sherry Benton, founder of digital behavioral health platform TAO Connect, a UF startup and UF Innovate | Accelerate at The Hub graduate.
Panbela Announces Positive Preclinical Data Strongly Supporting the Activity of SBP-101 in Ovarian Cancer Cell Lines
Panbela Therapeutics, Inc., formerly Sun Biopharma, a UF startup and clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, announced positive preclinical data supporting the activity of SBP-101 in ovarian cancer cell lines.
Digital Behavioral Health Platform TAO Connect Launches New Learner Dashboard, Offering Users Greater Personalization Experience
UF startup and UF Innovate | Accelerate at The Hub graduate TAO Connect, a digital platform designed to make behavioral health care more accessible and effective, announced the launch of its brand new Learner Dashboard.